April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Analysis of IgM Autoantibody Patterns as Marker for Acute Phase Immunoreactions in Pseudoexfoliation Glaucoma
Author Affiliations & Notes
  • M. Schlich
    Experimental Ophthalmology, University of Mainz, Mainz, Germany
  • K. Lorenz
    Experimental Ophthalmology, University of Mainz, Mainz, Germany
  • N. Boehm
    Experimental Ophthalmology, University of Mainz, Mainz, Germany
  • C. Kramann
    Experimental Ophthalmology, University of Mainz, Mainz, Germany
  • N. Pfeiffer
    Experimental Ophthalmology, University of Mainz, Mainz, Germany
  • F. H. Grus
    Experimental Ophthalmology, University of Mainz, Mainz, Germany
  • Footnotes
    Commercial Relationships  M. Schlich, None; K. Lorenz, None; N. Boehm, None; C. Kramann, None; N. Pfeiffer, None; F.H. Grus, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4846. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Schlich, K. Lorenz, N. Boehm, C. Kramann, N. Pfeiffer, F. H. Grus; Analysis of IgM Autoantibody Patterns as Marker for Acute Phase Immunoreactions in Pseudoexfoliation Glaucoma. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4846.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : In previous studies significant alterations in IgG autoantibody patterns of pseudoexfoliation glaucoma patients (PEXG) could be demonstrated. However, reactivities of IgM autoantibodies, which may indicate acute immunological processes in the context of disease progression, have not been studied yet. Therefore, we analyzed IgM autoantibody patterns of PEXG patients compared to control subjects (CO). Additionally we included pseudoexfoliation syndrome patients (PEXS), showing no signs of glaucoma, in order to detect potential markers in patients who might switch from PEXS to PEXG.

Methods: : Sera of patients with PEXG (n=45), PEXS (n=19) and normal controls with cataract (n=39) were used for antibody analysis. Analyses were performed using protein-microarrays, which were prepared by spotting 56 different ocular antigens onto microarray slides. Arrays were incubated with sera (1:250), and were treated with a fluorescence labeled anti-IgM antibody for visualization of the antibody-antigen-reactions. Emitted signals were digitized and spot intensities were compared using diverse statistical techniques, such as ANOVA and multivariate discriminant analysis.

Results: : The comparison of IgM autoantibody reactivities from PEXG and CO subjects revealed several significantly increased autoantibody reactivities in the glaucoma group, e.g. anti-α-1-Antitrypsin, anti-Glyceraldehyd-3-Phosphatase or anti-Protein-S100 (P<0.001). Interestingly, patterns from PEXS patients compared to those from CO subjects showed the same differences as PEXG for most autoantibodies, e.g. increased reactivities for anti-α-1-Antitrypsin or anti-Protein S100 (P<0.01). Furthermore, we found autoantibodies which differentiate between PEXG and PEXS like anti-γ-Synuclein, anti-heat shock protein 27 and anti-γ-Crystalin (P≤0.05).

Conclusions: : The analysis of IgM autoantibody patterns revealed multiple significant shifts in immunoreactivities of PEXG and PEXS patients. Autoantibody intensities with strongly increased values were found in these patients, indicating acute immunological processes.

Keywords: autoimmune disease • immunomodulation/immunoregulation • detection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×